The great escape: Is immune evasion required for tumor progression?
Andreas Villunger
& Andreas Strasser
Walter & Eliza Hall Institute for Medical Research
P.O. Royal Melbourne Hospital Victoria 3050
Australia strasser@wehi.edu.au
A study on page 938 reports the identification of an ovarian and uterine
tumor-associated ligand, RCAS1, which inhibits growth of activated T lymphocytes.